These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9522631)

  • 21. [How to identify individuals with elevated cardiovascular risk?].
    Klemsdal TO; Tonstad S; Hjermann I
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):799-801. PubMed ID: 15039814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention-oriented primary care: a collaborative model for office-based cardiovascular risk reduction.
    Feinstein RE
    Heart Dis; 1999; 1(5):264-71. PubMed ID: 11720633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease.
    Hengstenberg C; Holmer SR; Mayer B; Engel S; Schneider A; Löwel H; Riegger GA; Schunkert H
    Eur Heart J; 2001 Jun; 22(11):926-33. PubMed ID: 11428816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL; Wang EE
    CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention in cardiovascular pathology].
    Chamontin B; Amar J
    Therapie; 2001; 56(2):119-24. PubMed ID: 11471362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of preventive cardiology on coronary artery disease.
    Elford RW; Yeo M
    CMAJ; 1988 Oct; 139(8):719-24. PubMed ID: 3139276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quality of life in patients with risk factors of coronary heart disease].
    Kwaśniewska M; Drygas W
    Przegl Lek; 2005; 62(9):863-70. PubMed ID: 16541719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research.
    Kavey RE; Allada V; Daniels SR; Hayman LL; McCrindle BW; Newburger JW; Parekh RS; Steinberger J; ; ; ; ; ; ; ; ;
    J Cardiovasc Nurs; 2007; 22(3):218-53. PubMed ID: 17545824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk factor distribution according to the obesity degree in patients with coronary artery disease].
    Sönmez K; Akçakoyun M; Demir D; Akçay A; Pala S; Duran NE; Bakal RB; Gençbay M; Değertekin M; Turan F
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):203-10. PubMed ID: 12223326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for coronary artery disease in patients with diabetes.
    Bax JJ; Young LH; Frye RL; Bonow RO; Steinberg HO; Barrett EJ;
    Diabetes Care; 2007 Oct; 30(10):2729-36. PubMed ID: 17901530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Statins in secondary prevention of coronary heart disease].
    Sandhofer F
    Wien Med Wochenschr; 1999; 149(5-6):125-8. PubMed ID: 10408003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.
    Nishtar S; Faruqui AM; Mattu MA; Mohamud KB; Ahmed A
    J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S14-25. PubMed ID: 15745323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiologic basis for population-wide cholesterol reduction in the primary prevention of coronary artery disease.
    Pearson TA
    Am J Cardiol; 2004 Nov; 94(9A):4F-8F. PubMed ID: 15519285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for primary coronary heart disease prevention.
    Epstein FH
    Cor Vasa; 1993; 35(1):16-9. PubMed ID: 8444035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physiopathologic introduction to anesthesia and resuscitation of the vascular patient].
    Coriat P
    J Mal Vasc; 1998 Feb; 23(1):35-40. PubMed ID: 9551351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protecting the heart: a practical review of the statin studies.
    Ong HT
    MedGenMed; 2002 Dec; 4(4):1. PubMed ID: 12817199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and prevention of atherosclerosis: specific prevention directed to the high-risk patients.
    Epstein FH
    Acta Cardiol Suppl; 1988; 29():141-50. PubMed ID: 3389024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The health farm concept in the primary prevention of coronary artery disease.
    Ahmad AM
    Singapore Med J; 1995 Dec; 36(6):600-5. PubMed ID: 8781629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.